Evidence mapPaperPMID 40924950Full record

ArticleJournal of proteome research2025

Uncovering Urinary Proteome Differences in Very Preterm Infants with and without Preterm Brain Injury.

Magdalena Zasada, Maciej Suski, Marta Olszewska, Aleksandra Kowalik, Natalia Łapińska, Weronika Pogoda, Przemko Kwinta

Abstract read
In one paragraph

Article in Journal of proteome research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Magdalena ZasadaDepartment of Pediatrics, Jagiellonian University Medical College, Wielicka 265 Street, 30-663 Krakow, Poland.ORCID 0000-0003-0459-7046
Maciej SuskiDepartment of Pharmacology, Jagiellonian University Medical College, Faculty of Medicine, Grzegórzecka 16 Street, 31-531 Krakow, Poland.
Marta OlszewskaDepartment of Pediatrics, Jagiellonian University Medical College, Wielicka 265 Street, 30-663 Krakow, Poland.
Aleksandra KowalikDepartment of Pediatrics, Jagiellonian University Medical College, Wielicka 265 Street, 30-663 Krakow, Poland.
Natalia ŁapińskaDepartment of Pharmaceutical Technology and Biopharmaceutics, Jagiellonian University Medical College, Faculty of Pharmacy, Medyczna 9 Street, 30-688 Krakow, Poland.ORCID 0000-0001-6660-4446
Weronika PogodaProteomics Laboratory, Centre for the Development of Therapies for Civilization and Age-Related Diseases CDT-CARD, Jagiellonian University Medical College, Skawińska 8 Street, 31-066 Krakow, Poland.
Przemko KwintaDepartment of Pediatrics, Jagiellonian University Medical College, Wielicka 265 Street, 30-663 Krakow, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Premature infants are at high risk for brain injuries such as intraventricular hemorrhage and periventricular white matter injury. This study applies omics technology to analyze urinary protein expression, aiming to clarify preterm brain injury mechanisms and identify therapeutic targets. Urine samples were collected from 29 very preterm infants (VPI) without brain injury and 11 with moderate/severe injury at eight time points: Days 1, 2, 3, 4, 6, 8, 28, and term-equivalent age (TEA). Brain damage was assessed using the Kidokoro scale and MRI at TEA. SWATH-MS and bioinformatics were used to identify differentially expressed urinary proteins and affected pathways. Fifty-six proteins showed significant expression differences. Notably, extracellular proteoglycans (NCAN, ACAN, BCAN), associated with neuroprotection, were markedly reduced in infants with brain injury. Conversely, fatty acid-binding proteins (FABP1, FABP3, FABP4, FABP7) decreased over time in uninjured infants but increased in those with brain injury, suggesting a role in exacerbating damage. In summary, the urinary proteome of VPI with moderate/severe brain injury differs significantly from those without injury. Reduced neuroprotective proteoglycans and elevated FABPs highlight potential molecular markers and targets for intervention in preterm brain injury.

Indexed as

Brain InjuriesInfant, Extremely PrematureProteomeBiomarkersFatty Acid-Binding ProteinsFemaleHumansInfant, NewbornInfant, PrematureMaleProteoglycansProteomicsBiomarkersFatty Acid-Binding ProteinsProteoglycansProteomefatty acid-binding proteinsintraventricular hemorrhageperiventricular white matter injuryprematuritypreterm brain injuryproteoglycansurinary proteome

Identifiers

PMID40924950
PMCPMC12501990

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.